Review




Structured Review

Sengenics Corporation Pte i-ome discovery protein microarray
I Ome Discovery Protein Microarray, supplied by Sengenics Corporation Pte, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/i-ome+discovery+protein+microarray/cta+protein+array/pm40348637-76-25-29
Average 90 stars, based on 1 article reviews
i-ome discovery protein microarray - by Bioz Stars, 2026-11
90/100 stars

Images

Related Articles

Gene Expression:

Article Title: Novel IgG and IgA autoantibodies validated in two independent cohorts are associated with disease activity and determine organ manifestations in systemic lupus erythematosus: implications for anti-LIN28A, anti-HMGN5, anti-IRF5, and anti-TGIF1.
Article Snippet: Autoantibody measurement and gene expression analysis Plasma samples were screened for IgG and IgA autoantibody specificities against a panel of 1609 human proteins using the i-Ome Discovery protein microarray (Sengenics Corporation; Supplementary Material, sheet 1) [23].

Article Title: Novel IgG and IgA autoantibodies validated in two independent cohorts are associated with disease activity and determine organ manifestations in systemic lupus erythematosus: implications for anti-LIN28A, anti-HMGN5, anti-IRF5, and anti-TGIF1.
Article Snippet: To address this need, we aimed to uncover novel biomarkers that could enhance our ability to monitor SLE disease activity more accurately and tailor treatments more effectively using the i-Ome Discovery protein microarray (Sengenics Corporation) that encompasses 1609 protein autoantigens.

Clinical Proteomics:

Article Title: Novel IgG and IgA autoantibodies validated in two independent cohorts are associated with disease activity and determine organ manifestations in systemic lupus erythematosus: implications for anti-LIN28A, anti-HMGN5, anti-IRF5, and anti-TGIF1.
Article Snippet: Autoantibody measurement and gene expression analysis Plasma samples were screened for IgG and IgA autoantibody specificities against a panel of 1609 human proteins using the i-Ome Discovery protein microarray (Sengenics Corporation; Supplementary Material, sheet 1) [23].

Article Title: Novel IgG and IgA autoantibodies validated in two independent cohorts are associated with disease activity and determine organ manifestations in systemic lupus erythematosus: implications for anti-LIN28A, anti-HMGN5, anti-IRF5, and anti-TGIF1.
Article Snippet: To address this need, we aimed to uncover novel biomarkers that could enhance our ability to monitor SLE disease activity more accurately and tailor treatments more effectively using the i-Ome Discovery protein microarray (Sengenics Corporation) that encompasses 1609 protein autoantigens.

Microarray:

Article Title: Novel IgG and IgA autoantibodies validated in two independent cohorts are associated with disease activity and determine organ manifestations in systemic lupus erythematosus: implications for anti-LIN28A, anti-HMGN5, anti-IRF5, and anti-TGIF1.
Article Snippet: Autoantibody measurement and gene expression analysis Plasma samples were screened for IgG and IgA autoantibody specificities against a panel of 1609 human proteins using the i-Ome Discovery protein microarray (Sengenics Corporation; Supplementary Material, sheet 1) [23].

Article Title: Novel IgG and IgA autoantibodies validated in two independent cohorts are associated with disease activity and determine organ manifestations in systemic lupus erythematosus: implications for anti-LIN28A, anti-HMGN5, anti-IRF5, and anti-TGIF1.
Article Snippet: To address this need, we aimed to uncover novel biomarkers that could enhance our ability to monitor SLE disease activity more accurately and tailor treatments more effectively using the i-Ome Discovery protein microarray (Sengenics Corporation) that encompasses 1609 protein autoantigens.

Activity Assay:

Article Title: Novel IgG and IgA autoantibodies validated in two independent cohorts are associated with disease activity and determine organ manifestations in systemic lupus erythematosus: implications for anti-LIN28A, anti-HMGN5, anti-IRF5, and anti-TGIF1.
Article Snippet: Autoantibody measurement and gene expression analysis Plasma samples were screened for IgG and IgA autoantibody specificities against a panel of 1609 human proteins using the i-Ome Discovery protein microarray (Sengenics Corporation; Supplementary Material, sheet 1) [23].

Article Title: Novel IgG and IgA autoantibodies validated in two independent cohorts are associated with disease activity and determine organ manifestations in systemic lupus erythematosus: implications for anti-LIN28A, anti-HMGN5, anti-IRF5, and anti-TGIF1.
Article Snippet: To address this need, we aimed to uncover novel biomarkers that could enhance our ability to monitor SLE disease activity more accurately and tailor treatments more effectively using the i-Ome Discovery protein microarray (Sengenics Corporation) that encompasses 1609 protein autoantigens.

Immunopeptidomics:

Article Title: Novel IgG and IgA autoantibodies validated in two independent cohorts are associated with disease activity and determine organ manifestations in systemic lupus erythematosus: implications for anti-LIN28A, anti-HMGN5, anti-IRF5, and anti-TGIF1.
Article Snippet: Autoantibody measurement and gene expression analysis Plasma samples were screened for IgG and IgA autoantibody specificities against a panel of 1609 human proteins using the i-Ome Discovery protein microarray (Sengenics Corporation; Supplementary Material, sheet 1) [23].

Article Title: Novel IgG and IgA autoantibodies validated in two independent cohorts are associated with disease activity and determine organ manifestations in systemic lupus erythematosus: implications for anti-LIN28A, anti-HMGN5, anti-IRF5, and anti-TGIF1.
Article Snippet: To address this need, we aimed to uncover novel biomarkers that could enhance our ability to monitor SLE disease activity more accurately and tailor treatments more effectively using the i-Ome Discovery protein microarray (Sengenics Corporation) that encompasses 1609 protein autoantigens.



Similar Products

90
Sengenics Corporation Pte i-ome discovery protein microarray
I Ome Discovery Protein Microarray, supplied by Sengenics Corporation Pte, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/i-ome+discovery+protein+microarray/cta+protein+array/pm40348637-76-25-29
Average 90 stars, based on 1 article reviews
i-ome discovery protein microarray - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results